SCHEMBL4100641

SCHEMBL4100641

O=[PH](OCS)OCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7923540 0.75 CA1 (0.34)
SCHEMBL4100643 0.72
SCHEMBL3362805 0.72
SCHEMBL2530499 0.67
SCHEMBL8368343 0.65 HDAC3 (0.33)
SCHEMBL28396418 0.65
SCHEMBL2339736 0.64 HDAC3 (0.32)
SCHEMBL16667070 0.64 HDAC3 (0.37)
SCHEMBL17183014 0.64 HDAC3 (0.37)
SCHEMBL669658 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4352015-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS Numat Technologies Inc. (US) 2024-04-17 EP claimed
US-20230038608-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS NUMAT TECHNOLOGIES, INC. (US) 2023-02-09 US claimed
WO-2023003823-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS NUMAT TECHNOLOGIES, INC. (US) 2023-01-26 WO claimed
EP-4352015-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS Numat Technologies Inc. (US) 2024-04-17 EP disclosed
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed
US-11642650-B2 Metal organic frameworks for removal of elemental impurities in pharmaceutical products NUMAT TECHNOLOGIES INC. (US) 2023-05-09 US disclosed
EP-4149655-A1 METAL ORGANIC FRAMEWORKS FOR REMOVAL OF ELEMENTAL IMPURITIES IN PHARMACEUTICAL PRODUCTS Numat Technologies Inc. (US) 2023-03-22 EP disclosed
US-20230038608-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS NUMAT TECHNOLOGIES, INC. (US) 2023-02-09 US disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 US disclosed
WO-2023003823-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS NUMAT TECHNOLOGIES, INC. (US) 2023-01-26 WO disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
EP-1663254-A2 ANTI-INFLAMATORY PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2006-06-07 EP disclosed
US-20060035866-A1 Phosphonate compounds having immuno-modulatory activity GILEAD SCIENCES, INC. 2006-02-16 US disclosed
EP-1620110-A2 IMMUNOMODULATOR PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2006-02-01 EP disclosed
WO-2004100960-A2 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS GILEAD SCIENCES, INC. (US) 2004-11-25 WO disclosed
WO-2004096236-A2 IMMUNOMODULATOR PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2004-11-11 WO disclosed
US-6770451-B2 BIOLOGICAL CONJUGATION WITH AN ENZYME DONOR, ENZYME ACCEPTOR, AND A SUBSTRATE, COMPETETIVE BINDING, DETECTING KINASES OR PHOSPHATASES DISCOVERX, INC. 2004-08-03 US disclosed
EP-1392870-A1 SCREENING FOR ENZYME INHIBITORS Discoverx, Inc. (US) 2004-03-03 EP disclosed
US-20030170765-A1 Screening for enzyme inhibitors EUROFINS DISCOVERX CORPORATION 2003-09-11 US disclosed
WO-2002090593-A1 SCREENING FOR ENZYME INHIBITORS DISCOVERX, INC. (US) 2002-11-14 WO disclosed